Jane Street
HCWB icon

Jane Street’s HCW Biologics HCWB Stock Holding History

Jane Street’s Portfolio HCWB Stock Details HCWB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
52,138
+49,782
+2,113% +$282K ﹤0.01% 9516
2026
Q1 		$5.09K Buy
+2,356
New +$12.2K ﹤0.01% 11354
2024
Q3 		– Sell
-101
Closed -$15.6K – 9900
2024
Q2 		$15.6K Buy
101
+29
+40% +$8.57K ﹤0.01% 9062
2024
Q1 		$30.2K Buy
+72
New +$23K ﹤0.01% 8840

Other funds holding HCWB

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Jane Street's HCWB Position: Q2 2026 in Review

Jane Street increased its HCW Biologics (HCWB) stake by 2,113% in Q2 2026, buying an estimated $282K and bringing the position to 52,138 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #9516.

Jane Street first reported a position in HCWB in Q1 2024 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold HCWB as of Q2 2026.

  • Jane Street held 52,138 shares of HCW Biologics worth $260K as of Q2 2026.
  • Jane Street bought 49,782 HCW Biologics shares in Q2 2026, an estimated $282K.
  • HCW Biologics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9516 holding.
  • Jane Street first reported a position in HCW Biologics in Q1 2024 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held HCW Biologics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.